Toxic shock syndrome epidemiology and demographics

Jump to navigation Jump to search

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome epidemiology and demographics

CDC on Toxic shock syndrome epidemiology and demographics

Toxic shock syndrome epidemiology and demographics in the news

Blogs on Toxic shock syndrome epidemiology and demographics

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome epidemiology and demographics

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

General Incidence and Prevalance

  • TSS became a nationally notifiable disease in 1980. After the initial epidemic, the number of reported cases decreased significantly. Active surveillance during 1986 which was conducted in various parts of the United States confirms the decreasing trend. The total incidence (0.5 per 100,000 population) confirmed the substantial decrease in the incidence of menstrual TSS observed in the passive surveillance system. Incidence rates declined from 6 to 12 per 100,000 among women 12-49 years of age (10,11) in 1980 to 1 per 100,000 among women 15-44 years of age in 1986.[1] Apart from menstruation associated TSS, non-menstruating cases having a skin or soft tissue infection have also been identified.[2]
  • In a study conducted during 2000-2006, the average annual incidence per 100,000 persons of all TSS cases was 0.52 cases (95% CI, 0.32–0.77), of menstrual cases was 0.69 (95% CI, 0.39–1.16), and of non-menstrual cases was 0.32 (95% CI, 0.12–0.67). Women aged 13–24 years had the highest incidence with an annual rate of menstrual TSS of 1.41 cases per 100,000.  [3]
  • MRSA strains have increased in prevalence during the last decade and MRSA have been reported as the cause of TSS.[4]

Gender based differences

  • Approximately half the cases of staphylococcal TSS reported today are associated with tampon use during menstruation, usually in young women, though TSS also occurs in children, men, and non-menstruating women.
  • Women aged 13–24 years had the highest incidence with an annual rate of menstrual TSS of 1.41 cases per 100,000 based on incidence data from 2000-2003.
  • It has been estimated that each year 1 to 17 of every 100,000 menstruating females will get TSS. In the US in 1997, only five confirmed menstrual-related TSS cases were reported, compared with 814 cases in 1980, according to data from the Centers for Disease Control and Prevention (CDC).
  1. "Toxic Shock Syndrome in the United States: Surveillance Update, 1979–19961 - Volume 5, Number 6—December 1999 - Emerging Infectious Disease journal - CDC".
  2. DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, Lynfield R (2011). "Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics". PLoS ONE. 6 (8): e22997. doi:10.1371/journal.pone.0022997. PMC 3157910. PMID 21860665.
  3. DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, Lynfield R (2011). "Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics". PLoS ONE. 6 (8): e22997. doi:10.1371/journal.pone.0022997. PMC 3157910. PMID 21860665.
  4. DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, Lynfield R (2011). "Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics". PLoS ONE. 6 (8): e22997. doi:10.1371/journal.pone.0022997. PMC 3157910. PMID 21860665.


Template:WikiDoc Sources